Back to Search
Start Over
Glypican-3 antibodies: A new therapeutic target for liver cancer.
- Source :
-
FEBS Letters . Jan2014, Vol. 588 Issue 2, p377-382. 6p. - Publication Year :
- 2014
-
Abstract
- Highlights: [•] Updated information on GPC3 as a new target in liver cancer. [•] GPC3-targeting antibodies that are currently being evaluated for therapeutic purposes. [•] Potential challenges for GPC3-targeted immunotherapy. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 00145793
- Volume :
- 588
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- FEBS Letters
- Publication Type :
- Academic Journal
- Accession number :
- 93689151
- Full Text :
- https://doi.org/10.1016/j.febslet.2013.10.002